AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Siemens Healthineers AG
Video analysis: SEMHF
All videosNo video analysis for this stock yet. Request one from our team.
News: SEMHF
Siemens Healthineers (OTCMKTS:SEMHF) Stock Price Down 0.4% – Here’s What Happened
Siemens Healthineers AG (OTCMKTS:SEMHF - Get Free Report) traded down 0.4% during mid-day trading on Tuesday. The company traded as low as $45.0450 and last traded at $45.0450. 3,072 shares changed hands during trading, a decline of 29% from the average daily volume of 4,328 shares. The stock had previously closed at $45.2325. Siemens
Siemens Healthineers: Successful Investment, Updating For H2 2026
Siemens Healthineers remains a high-conviction BUY with a reiterated €48/share price target, reflecting strong Imaging and Precision Therapy segments. I exclude Chinese recovery from my base case; growth is now driven by ex-China Imaging and Varian, with diagnostics seen as structurally impaired. 3Q26 results confirmed robust order momentum (1.3x book-to-bill), and margin strength (19.1%), and EPS guidance raised to €2.45, though tariff refunds contributed.
Siemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness
The German supplier of medical equipment now expects fiscal-year revenue to grow by between 3.5% and 4.0% on a comparable basis, compared with 4.5% to 5% previously.
Siemens Healthineers cuts revenue forecast citing diagnostics weakness
Medical technology firm Siemens Healthineers cut its 2026 revenue growth forecast on Friday to a range of 3.5% to 4.0%, as China's procurement policy weighs on its diagnostics business.
